three days Initial Public Offering (IPO) Supriya Lifesciences Ltd was subscribed 71.51 times on the last day of the share sale ended December 20. The finalization of the share allotment basis for Supriya Lifesciences IPO was completed last week and the company’s shares are expected to be listed on Tuesday, December this week. On 28 major stock exchanges NSE and BSE.
According to market experts, there has been a jump in the share premium (GMP) of Supriya Lifesciences. 150 in the gray market today compared to about 150 In the previous session 135. Gray Market is an informal platform where trading starts after the announcement of the IPO price band till the listing of the shares.
The latest issue in the initial share sale of Supriya Lifescience was 200 crore and offer for sale 500 crores. its price range was 265-274 per share. the company had taken 315 crore from anchor investors before its IPO.
The issue was fully subscribed within a few hours on the first day of subscription opening on December 16. The proceeds from the fresh issue will be used to finance capital expenditure requirements, debt repayment and general corporate purposes.
Supriya Lifescience is one of the leading Indian manufacturers and suppliers of active pharmaceutical ingredients, focusing on research and development. As of October 31, 2021, the company had product offerings of 38 APIs focused on diverse therapeutic segments such as Antihistamine, Analgesic, Anesthetic, Vitamin, Anti-Asthma and Anti-Allergy.
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,